Log In
Print
BCIQ
Print
Print this Print this
 

vesigenurtacel-L (HS-410)

  Manage Alerts
Collapse Summary General Information
Company Heat Biologics Inc.
DescriptionCompound using Heat Biologics Immune Pan-Antigen Cytotoxic Therapy (ImPACT) technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationBladder cancer
Indication DetailsTreat bladder cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today